RT Book, Section
A1 Hughes, Walter T.
A2 Rudolph, Colin D.
A2 Rudolph, Abraham M.
A2 Lister, George E.
A2 First, Lewis R.
A2 Gershon, Anne A.
SR Print(0)
ID 7032071
T1 Chapter 353. Pneumocystis Pneumonia
T2 Rudolph's Pediatrics, 22e
YR 2011
FD 2011
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-149723-7
LK accesspediatrics.mhmedical.com/content.aspx?aid=7032071
RD 2024/04/19
AB Pneumocystis  pneumonia  (PCP)  occurs  almost  exclusively  in  the  severely  immunocompromised  host,  especially  patients  with  congenital  immunodeficiency  diseases,  AIDS,  and  cancer,  and  those  who  have  had  organ  transplantation.  Once  pneumonia  is  apparent,  the  fatality  rate  is  near  100%  if  untreated.  Effective  therapeutic  and  prophylactic  drugs  are  available.  The  causative  agent  is  a  protozoan-like  fungus  known  for  the  past  century  as  Pneumocystis  carinii.  Recently,  the  term  Pneumocystis  jirovecii  has  been  proposed  for  the  organism  found  in  humans,1  but  acceptance  has  not  been  universal.2